PDB Short entry for 2QTU HEADER TRANSCRIPTION REGULATOR 02-AUG-07 2QTU TITLE ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN TITLE 2 LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR BETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: ER-BETA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR2, ESTRB, NR3A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS NUCLEAR RECEPTOR, LIGAND-BINDING DOMAIN, ALTERNATIVE SPLICING, DNA- KEYWDS 2 BINDING, LIPID-BINDING, METAL-BINDING, NUCLEUS, PHOSPHORYLATION, KEYWDS 3 STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, KEYWDS 4 ZINC-FINGER, TRANSCRIPTION REGULATOR EXPDTA X-RAY DIFFRACTION AUTHOR T.I.RICHARDSON,J.A.DODGE,Y.WANG,J.D.DURBIN,V.KRISHNAN,B.H.NORMAN REVDAT 3 21-FEB-24 2QTU 1 REMARK SEQADV REVDAT 2 24-FEB-09 2QTU 1 VERSN REVDAT 1 30-OCT-07 2QTU 0 JRNL AUTH T.I.RICHARDSON,J.A.DODGE,Y.WANG,J.D.DURBIN,V.KRISHNAN, JRNL AUTH 2 B.H.NORMAN JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 (SERBAS). PART 5: COMBINED A- AND C-RING STRUCTURE-ACTIVITY JRNL TITL 3 RELATIONSHIP STUDIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 5563 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17804226 JRNL DOI 10.1016/J.BMCL.2007.08.009 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1470249.280 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 18672 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.264 REMARK 3 R VALUE (WORKING SET) : 0.264 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1028 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2652 REMARK 3 BIN R VALUE (WORKING SET) : 0.3780 REMARK 3 BIN FREE R VALUE : 0.4180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.034 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 70.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.36000 REMARK 3 B22 (A**2) : -1.36000 REMARK 3 B33 (A**2) : 2.73000 REMARK 3 B12 (A**2) : -0.34000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.51 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.49 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.56 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.450 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.510 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.070 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.150 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 57.23 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2QTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044047. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18673 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 31.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.200 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.58200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, 2 M NACL, 4% PEG 6000, REMARK 280 PH 8.0, VAPOR DIFFUSION, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.20533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 166.41067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 124.80800 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 208.01333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.60267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASU FORMS A BIOLOGICAL ASSEMBLY (DIMER). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3270 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 HIS A 254 REMARK 465 HIS A 255 REMARK 465 ARG A 256 REMARK 465 GLU A 257 REMARK 465 LEU A 258 REMARK 465 LEU A 259 REMARK 465 LEU A 260 REMARK 465 SER A 286 REMARK 465 ALA A 287 REMARK 465 PRO A 288 REMARK 465 PHE A 289 REMARK 465 THR A 290 REMARK 465 GLU A 291 REMARK 465 THR A 415 REMARK 465 ALA A 416 REMARK 465 THR A 417 REMARK 465 GLN A 418 REMARK 465 ASP A 419 REMARK 465 ALA A 420 REMARK 465 ASP A 421 REMARK 465 CYS A 481 REMARK 465 LYS A 482 REMARK 465 ASN A 483 REMARK 465 VAL A 484 REMARK 465 VAL A 485 REMARK 465 PRO A 486 REMARK 465 VAL A 499 REMARK 465 LEU A 500 REMARK 465 ARG A 501 REMARK 465 GLY A 502 REMARK 465 CYS A 503 REMARK 465 LYS A 504 REMARK 465 SER A 505 REMARK 465 MET B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 HIS B 254 REMARK 465 HIS B 255 REMARK 465 ARG B 256 REMARK 465 GLU B 257 REMARK 465 LEU B 258 REMARK 465 LEU B 259 REMARK 465 SER B 286 REMARK 465 ALA B 287 REMARK 465 PRO B 288 REMARK 465 PHE B 289 REMARK 465 THR B 290 REMARK 465 GLU B 291 REMARK 465 THR B 415 REMARK 465 ALA B 416 REMARK 465 THR B 417 REMARK 465 GLN B 418 REMARK 465 ASP B 419 REMARK 465 ALA B 420 REMARK 465 ASP B 421 REMARK 465 CYS B 481 REMARK 465 LYS B 482 REMARK 465 ASN B 483 REMARK 465 VAL B 484 REMARK 465 VAL B 485 REMARK 465 PRO B 486 REMARK 465 ARG B 501 REMARK 465 GLY B 502 REMARK 465 CYS B 503 REMARK 465 LYS B 504 REMARK 465 SER B 505 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 261 CG OD1 OD2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 480 CG CD CE NZ REMARK 470 ARG B 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 480 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 283 64.04 65.55 REMARK 500 ASP A 359 33.68 -142.41 REMARK 500 LEU A 360 74.48 -152.80 REMARK 500 GLU A 366 -7.25 -58.53 REMARK 500 PRO A 412 10.44 -63.04 REMARK 500 LYS A 443 7.82 -67.31 REMARK 500 SER B 283 72.70 57.81 REMARK 500 CYS B 369 -70.57 -46.86 REMARK 500 PRO B 412 5.72 -62.16 REMARK 500 LYS B 443 3.52 -66.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3AS A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3AS B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2I0G RELATED DB: PDB REMARK 900 RELATED ID: 2JJ3 RELATED DB: PDB REMARK 900 RELATED ID: 2Z4B RELATED DB: PDB DBREF 2QTU A 256 505 UNP Q92731 ESR2_HUMAN 256 505 DBREF 2QTU B 256 505 UNP Q92731 ESR2_HUMAN 256 505 SEQADV 2QTU MET A 249 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 250 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 251 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 252 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 253 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 254 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS A 255 UNP Q92731 EXPRESSION TAG SEQADV 2QTU MET B 249 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 250 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 251 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 252 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 253 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 254 UNP Q92731 EXPRESSION TAG SEQADV 2QTU HIS B 255 UNP Q92731 EXPRESSION TAG SEQRES 1 A 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 A 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 A 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 A 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 A 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 A 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 A 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 A 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 A 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 A 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 A 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 A 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 A 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 A 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 A 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 A 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 A 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 A 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER SEQRES 1 B 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 B 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 B 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 B 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 B 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 B 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 B 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 B 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 B 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 B 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 B 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 B 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 B 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 B 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 B 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 B 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 B 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 B 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER HET 3AS A 1 26 HET 3AS B 1 26 HETNAM 3AS (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-6- HETNAM 2 3AS (METHOXYMETHYL)-1,2,3,3A,4,9B- HETNAM 3 3AS HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL FORMUL 3 3AS 2(C20 H20 F2 O4) FORMUL 5 HOH *2(H2 O) HELIX 1 1 SER A 264 ALA A 275 1 12 HELIX 2 2 ALA A 292 LYS A 315 1 24 HELIX 3 3 SER A 323 ILE A 348 1 26 HELIX 4 4 ASP A 365 LYS A 368 5 4 HELIX 5 5 GLY A 372 LEU A 390 1 19 HELIX 6 6 GLN A 393 SER A 408 1 16 HELIX 7 7 MET A 410 VAL A 414 5 5 HELIX 8 8 SER A 422 LYS A 443 1 22 HELIX 9 9 SER A 447 ASN A 478 1 32 HELIX 10 10 VAL A 487 HIS A 498 1 12 HELIX 11 11 LEU B 260 LEU B 263 5 4 HELIX 12 12 SER B 264 ALA B 275 1 12 HELIX 13 13 SER B 293 LYS B 315 1 23 HELIX 14 14 SER B 323 SER B 347 1 25 HELIX 15 15 ASP B 365 CYS B 369 5 5 HELIX 16 16 GLY B 372 LEU B 390 1 19 HELIX 17 17 GLN B 393 SER B 408 1 16 HELIX 18 18 MET B 410 VAL B 414 5 5 HELIX 19 19 SER B 422 LYS B 443 1 22 HELIX 20 20 SER B 447 MET B 479 1 33 HELIX 21 21 VAL B 487 LEU B 500 1 14 SHEET 1 A 2 LYS A 353 ALA A 357 0 SHEET 2 A 2 LEU A 360 ASP A 363 -1 O LEU A 360 N ALA A 357 SHEET 1 B 2 LYS B 353 ALA B 357 0 SHEET 2 B 2 LEU B 360 ASP B 363 -1 O LEU B 362 N LEU B 354 SITE 1 AC1 14 LEU A 298 THR A 299 ALA A 302 GLU A 305 SITE 2 AC1 14 LEU A 339 ARG A 346 ILE A 373 ILE A 376 SITE 3 AC1 14 PHE A 377 LEU A 380 GLY A 472 HIS A 475 SITE 4 AC1 14 LEU A 476 VAL A 487 SITE 1 AC2 16 MET B 295 LEU B 298 THR B 299 ALA B 302 SITE 2 AC2 16 GLU B 305 MET B 336 LEU B 339 ARG B 346 SITE 3 AC2 16 ILE B 373 ILE B 376 PHE B 377 LEU B 380 SITE 4 AC2 16 GLY B 472 HIS B 475 LEU B 476 VAL B 487 CRYST1 63.798 63.798 249.616 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015674 0.009050 0.000000 0.00000 SCALE2 0.000000 0.018099 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004006 0.00000